Some regions statistically associated with grade III tumors in our study harbor genes either frequently amplified in aggressive breast cancer such as the oncogenes MYC (8q24) and CCNE1 (19q12) or already reported as deleted in breast tumors such as MTAP (9p21) [30]. This evidence concerns the gene MYC and breast neoplasm.